Centro Gaucho Integrado de Oncologia, Hematologia, Ensino e Pesquisa Ltda

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Melanoma1 trial
• Myeloproliferative neoplasms1 trial

Phase

• Phase 32 trials

Status

• Active, not recruiting1 trial
• Recruiting1 trial

Lead sponsor

• Geron Corporation1 trial
• Immunocore Ltd1 trial

Running trials

• Recruiting

  IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)

  NCT06112314· Phase 3· Immunocore Ltd· Source

  Contact: Alan Azambuja, MD

• Active, not recruiting

  A Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of Intermediate-2 or High-risk Myelofibrosis (MF) Who Have Not Responded to Janus Kinase (JAK)-Inhibitor Treatment

  NCT04576156· Phase 3· Geron Corporation· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Melanoma1 recruiting